Microbiologyopen 9, 110
Infrequent symptoms: Medications like levodopa or dopamine agonists used as needed
Editorial refresh Practical 2026 note for Semaglutide for CrossFit Athletes For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, crossfit, athletes so the article stays close to the question behind "Semaglutide for CrossFit Athletes"
Its a necessity The National Hispanic Health Foundation, National Hispanic Council on Aging, League of United Latin American Citizens, American Diabetes Association and the national Latina advocacy organization MANA published a joint policy brief in February, calling on New Mexico to allocate state funding to support Medicaid coverage of weight loss drugs to treat obesity
In FDA pharmacovigilance data, vomiting represented 24.6% of gastrointestinal adverse event reports
Between 20% and 50% of semaglutide users experience nausea, and slow titration has been shown to reduce that rate by approximately 30%